Your browser doesn't support javascript.
loading
In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline.
Kawashiri, Shin-Ya; Kawakami, Atsushi; Iwamoto, Naoki; Fujikawa, Keita; Aramaki, Toshiyuki; Tamai, Mami; Yamasaki, Satoshi; Nakamura, Hideki; Origuchi, Tomoki; Ueki, Yukitaka; Migita, Kiyoshi; Mizokami, Akinari; Aoyagi, Kiyoshi; Eguchi, Katsumi.
Affiliation
  • Kawashiri SY; Unit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. shin-ya@hotmail.co.jp
Mod Rheumatol ; 21(4): 370-4, 2011 Aug.
Article in En | MEDLINE | ID: mdl-21240618
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Rheumatoid Factor / Severity of Illness Index / Immunoglobulin M / Antibodies, Monoclonal, Humanized Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Mod Rheumatol Year: 2011 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Rheumatoid Factor / Severity of Illness Index / Immunoglobulin M / Antibodies, Monoclonal, Humanized Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Mod Rheumatol Year: 2011 Type: Article Affiliation country: Japan